Description of key strategic decisions facing the scientific founder and CEO of promising early stage bio-pharmaceutical company company.l should establish the proposed alliance with the pharmaceutical company? Whether it should create a nutraceuticals business in parallel to its efforts to develop an anti-aging treatment? And if he is licensed second candidate for drug development? "Hide
by Toby Stuart, David Kiron Source: Harvard Business School 24 pages. Publication Date: March 20, 2008. Prod. #: 808112-PDF-ENG
Related Case Solutions & Analyses:
Necessary Illusions and Dangerous Delusions
Thought Leader Interview: Bill George
Caterpillar Inc. (A)
Bloomex.ca Logistics Optimization Spreadsheet
What are Business Schools doing for Business today
Ratios Tell a Story-2005
Environmental Law in Real Estate Transactions
Dell Computer: Business to Business Over the Web in 2001
Merrill Lynch: Integrated Choice (Abridged)
Diamond in the Rough (B)
